Tengjun Biotechnology Corp. Net Change in Cash
Tengjun Biotechnology Corp. reported Net Change in Cash of $22.28 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-08-15
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $9.18M, a 553.53% increase year-over-year.
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $1.41M, a 30791.87% increase year-over-year.
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $4.55K.
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $2.55M, a 811.14% increase from fiscal 2021.
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $279.33K.
- Tengjun Biotechnology Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$62.51K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $22.28M 10-Q · filed 2023-08-15 | |||||||
| 2023-03-31 | $9.18M 10-Q · filed 2023-05-15 | |||||||
| 2022-12-31 | $2.55M 10-K · filed 2023-04-17 | |||||||
| 2022-09-30 | $3.61M 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | $6.47M 10-Q · filed 2023-08-15 | |||||||
| 2022-03-31 | $1.41M 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $279.33K 10-K · filed 2023-04-17 | |||||||
| 2021-09-30 | $12.72K 10-Q · filed 2022-11-14 | $18.44K 10-Q · filed 2021-10-20 | ||||||
| 2021-06-30 | $180.53K 10-Q/A · filed 2022-09-16 | $22.41K 10-Q · filed 2021-07-20 | ||||||
| 2021-03-31 | $4.55K 10-Q · filed 2022-05-13 | -$1.89K 10-Q · filed 2021-04-16 | ||||||
| 2020-12-31 | -$62.51K 10-K · filed 2022-03-31 | $5.94K 10-K · filed 2021-02-17 |